Swiss National Bank
IMNM icon

Swiss National Bank’s Immunome IMNM Stock Holding History

Swiss National Bank’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Sell
181,600
-3,400
-2% -$72.8K ﹤0.01% 1579
2026
Q1 		$4.05M Hold
185,000
– – ﹤0.01% 1473
2025
Q4 		$3.97M Buy
185,000
+50,000
+37% +$878K ﹤0.01% 1483
2025
Q3 		$1.58M Buy
135,000
+2,200
+2% +$21.9K ﹤0.01% 1962
2025
Q2 		$1.24M Buy
132,800
+4,800
+4% +$39.4K ﹤0.01% 2044
2025
Q1 		$861K Buy
128,000
+51,600
+68% +$495K ﹤0.01% 2191
2024
Q4 		$811K Hold
76,400
– – ﹤0.01% 2291
2024
Q3 		$1.12M Hold
76,400
– – ﹤0.01% 2165
2024
Q2 		$924K Buy
76,400
+5,000
+7% +$78.2K ﹤0.01% 2204
2024
Q1 		$1.76M Buy
+71,400
New +$1.45M ﹤0.01% 1911

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Swiss National Bank's IMNM Position: Q2 2026 in Review

Swiss National Bank reduced its Immunome (IMNM) stake by 1.8% in Q2 2026, selling an estimated $72.8K and leaving 181,600 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

Swiss National Bank first reported a position in IMNM in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.05M in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Swiss National Bank held 181,600 shares of Immunome worth $3.85M as of Q2 2026.
  • Swiss National Bank sold 3,400 Immunome shares in Q2 2026, an estimated $72.8K.
  • Immunome made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1579 holding.
  • Swiss National Bank first reported a position in Immunome in Q1 2024 and has held it in 10 quarters since.
  • Swiss National Bank's Immunome position peaked at $4.05M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.